Decrease of 99mTc-uptake in autonomous thyroid tissue in Germany since the 1970s: Clinical implications for radioiodine therapy

NuklearMedizin

Volumn 45, Issue 3, 2006, Pages 122-125

  Gotthardt, Martin ^a   Stubinger M ^b   Pansegrau, J ^b   Buchwald, B ^b   Goecke, J ^b   Pfestroff, A ^b   Corstens, F H M ^a   Behr, T M ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

Autonomy; Benign thyroid disorder; Plummers' disease; Radioiodine therapy; TcTUs

Indexed keywords

RADIOACTIVE IODINE; TECHNETIUM 99M; THYROTROPIN;

ANALYSIS OF VARIANCE; ARTICLE; BENIGN TUMOR; CONTROLLED STUDY; DIETARY INTAKE; EXPOSURE VARIABLE; GERMANY; HUMAN; HUMAN TISSUE; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; PILOT STUDY; RISK FACTOR; THYROID DISEASE; THYROID GLAND;

EID: 33745894331     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1625330     Document Type: Article

References (22)

1. Andersen BG, Powsner RA. Stability of values for thyroid radioiodine uptake. J Nucl Med 1996; 37: 805-6.
2. Becker W, Börner T, Rendl J. Is TSH screening useful in confirming or excluding functional thyroid autonomy? Nuklearmedizin 1992; 31: 132-6.
3. Dorbach M, Schicha H. Frequency and temporal occurrence of a functional autonomy in recurring goiter. Nuklearmedizin 1993; 32: 316-20.
4. Dietlein M, Dressler J, Grünwald F et al. Leitlinie zur Radiojodtherapie bei benignen Schilddrüsenerkrankungen (Version 3). Nuklearmedizin 2004; 43: 217-20.
5. Dunkelmann S, Endlicher D, Prillwitz A et al. Results of a TcTUs-optimized radioiodine therapy of multifocal and disseminated functional thyroid autonomy. Nuklearmedizin 1999; 38: 131-9.
6. Emrich D, Erlenmaier U, Pohl M et al. Determination of the autonomously functioning volume of the thyroid. Eur J Nucl Med 1993; 20: 410-4.
7. Gotthardt M, Nowak M, Béhé MP et al. Negative correlation between therapeutic success in radioiodine therapy and TcTUs: are TcTUs adapted dose concepts the only possible answer?. Eur J Nucl Med Mol Imag 2003; 30: 1165-8.
8. Huszno B, Hubalewska-Hola A, Baldys-Waligorska A et al. The impact of iodine prophylaxis on thyroid 131 -iodine uptake in the region of Krakow, Poland. J Endocrinol Invest 2003; 26 (2 suppl): 7-10.
9. Joseph K, Mahlstedt J, Pries HH et al. Early diagnosis and evaluation of the risk to develop hyperthyroidism in patients with autonomously functioning thyroid tissue. Nuc Compact 1977; 8: 134-9.
10. 99mTc-Speichertets asl Schätzer der thyreoiodalen Stimulation. FortschrRöngenstr 1979; 131: 536-44.
11. Melier J, Wisheu S, Munzel U et al. Radioiodine therapy for Plummer's disease based on the thyroid uptake of technetium-99m pertechnetate. Eur J Nucl Med 2000; 27: 1286-91.
12. 131I-Induced release of cold iodine stored in the thyroid. Nuklearmedizin 2005; 44: 137-42.
13. Meng W, Scriba C. Jodversorgung in Deutschland. Probleme und erforderliche Maßnahmen. Update 2002. Dtsch Ärztebl 2002; 99: A256-4.
14. Moorthy D, Sood A, Ahluwalia A et al. Radioiodine kinetics and thyroid function following the universal salt iodization policy. Natl Med J India 2001; 14: 71-4.
15. Parle JV, Maisonneuve P, Sheppard MC et al. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin results: a 10-year cohort study. Lancet 2001; 358: 861-5.
16. rd ed. Berlin: BMV 1997.
17. Pittman JA, Daily GE, Beschi RJ. Changing normal values for thyroidal radioiodine uptake. N Engl J Med 1968; 280: 1431-4.
18. Reinhardt MJ, Hogerle S, Trupkovic T et al. Influence of urinary iodine excretion on thyroid technetium-99m pertechnetate uptake with and without TSH suppression: what happens when iodine supply increases? Eur J Nucl Med 1998; 25: 1475-81.
19. 99mTc-pertechnetate thyroid uptake. Eur J Nucl Med 2002; 29: 480-5.
20. Sawin CT, Geller A, Wolf PA et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994; 331: 1249-52.
21. Schaffhauser K, Hänscheid H, Rendl J et al. Intrathyroidal iodine concentration after application of non-ionic contrast media with and without prophylactic application of perchlorate. Nuklear-medizin 2005; 44: 143-8.
22. www.nuklearmedizin.de/publikationen/leitlinien/schild_diagn.php